TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
XOMA

XOMA Royalty Corporation

Healthcare · Biotechnology

40.20$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement XOMA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+193.9% -90.0% +847.0% -89.9% +246.7% +60.0% +29.9% -84.2% -21.1% +498.7% +83.1%
-29.8% -93.2% +462.5% -78.6% -25.5% -86.4% +0.6% +60.2% -47.8% +44.1% +1,337.4%
-88.0% +976.2% -91.9% +373.2% +70.7% +30.0% -84.9% -19.8% +512.8% +73.9%
-12.3% -37.6% -82.2% -78.6% -25.5% -86.4% +0.6% -10.5% -6.5% +1,910.5% -40.5%
+3.8% -11.1% +32.8% -23.7% +13.1% -20.0% +21.8% +13.3% +10.4% +34.6% +4.7%
-9.1% -31.6% -48.5% -37.2% +3.7% -20.0% +21.8% +13.2% +100.6% +46.9% -44.6%
-199.0% +41.2% -199.3%
-2.3% -5.7% -68.6% -25.5% +108.1% -3.9% -75.0% -36.0% +92.9% +2,332.3% -5.8%
-182.7% +34.7% -207.7%
-0.5% +10.9% -64.5% -105.9% -126.3% -116.5% -872.8%
-191.4% +18.8% -208.3%
-160.1% +19.6% -202.0%

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?